LEXINGTON, Mass.--(BUSINESS WIRE)--Cubist Pharmaceuticals, Inc. (NASDAQ: CBST) today announced that Steven Gilman, EVP and CSO, will present on Wednesday, February 16, at 3:20 p.m. Eastern Time, at the Leerink Swann Hot Topics in Therapeutics Roundtable Conference being held at the Roosevelt Hotel in New York City. The webcast presentation will include a discussion of the company’s business activities, financial outlook, and current news.
